Since it is very difficult to achieve the ideal situation with monotherapy, attempts have been made to create a more ideal treatment for hypertension by combining complementary drugs in low doses.

Low-dose combination therapy provides several advantages in that: 1) it will be more effective than monotherapy due to the additive effect on BP of complementary drugs; 2) it will provide 24-hour ...

Patients managing diabetes, hypertension, and other cardiovascular conditions have been urged not to combine their routine ...

Drugs to treat gastrointestinal and cardiovascular diseases, painkillers and anti-diabetic medicines recorded the maximum ...

High blood pressure, also known as hypertension, is a common condition that affects millions globally. It occurs when the ...

Medically reviewed by Mary Choy, PharmD Amlodipine is a commonly prescribed calcium channel blocker medication used to treat ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

following New Drug Application (NDA) filed with FDA in August, GMRx2 would be the first triple combination approved for initial treatment of hypertension London, UK, 18 October 2024 – George ...

Novel combination pill significantly reduced blood pressure and improved control rates vs dual therapy, with good tolerability and no increase in adverse event related withdrawals Triple combination ...

The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance ...

Allschwil, Switzerland – November 11, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data on aprocitentan, the ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA) has ...